Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan / Carl Koschmann, MD |
Young Investigator Grants |
2014 |
Michigan |
Targeting the Epigenome of Diffuse Intrinsic Pontine Glioma |
The Johns Hopkins University School of Medicine / Sama Ahsan, MD |
Young Investigator Grants |
2014 |
Maryland |
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD |
Young Investigator Grants |
2014 |
Maryland |
Converting the Glioblastoma Multiforme Tumor-Associated Macrophage Phenotype |
The Johns Hopkins University School of Medicine / Alan D. Friedman, M.D. |
Innovation Grants |
2014 |
Maryland |
Targeted Inhibition of the DNA Damage Response Pathway: A Novel Intervention in the Treatment of Pediatric Leukemias |
National Cancer Institute / Andre Nussenzweig, Ph.D. |
Reach Grants |
2014 |
Maryland |
Targeting Tumor Suppressor MicroRNAs in Pediatric Acute Lymphoblastic Leukemia |
The Johns Hopkins University School of Medicine / Linda Resar, M.D. |
Innovation Grants |
2014 |
Maryland |
Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia |
National Cancer Institute / Christopher Chien, PhD |
Young Investigator Grants |
2014 |
Maryland |
Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer |
Boston University / Kristin Long, PhD |
Psychosocial Grants |
2014 |
Massachusetts |
SETD2 Mutations in Prognosis and Chemotherapy Resistance in Relapsed Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Brenton Mar, MD, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Targeting MYC/MYCN-driven Transcriptional Amplification in Pediatric Cancer |
Dana-Farber Cancer Institute / Rani George, M.D., Ph.D. |
Innovation Grants |
2014 |
Massachusetts |